NASDAQ : CRDF
Cardiff Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.8896 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 69.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cardiff Oncology, Inc. (CRDF) reported revenue of 508.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 508.00K | 593.00K | 683.00K | 488.00K | 386.00K | 359.00K |
| Cost of Revenue | 35.33M | 35.33M | 36.85M | 32.86M | 27.11M | 17.38M |
| Gross Profit | -34.82M | -34.74M | -36.17M | -32.37M | -26.72M | -17.02M |
| Selling, General & Admin | 16.82M | 14.22M | 12.48M | 13.04M | 13.18M | 11.84M |
| Operating Expenses | 7.45M | 14.22M | 12.48M | 13.04M | 13.18M | 11.84M |
| Operating Income | -42.27M | -48.96M | -48.65M | -45.41M | -39.90M | -28.86M |
| Interest & Investment Income | 2.22M | 3.10M | 3.26M | 4.07M | 1.58M | 264.00K |
| Other Non Operating Income (Expenses) | -1.00K | 5.00K | -39.00K | -98.00K | -383.00K | 300.00K |
| EBT Excluding Unusual Items | -40.05M | -45.85M | -45.43M | -41.44M | -38.70M | -28.29M |
| Pretax Income | -40.05M | -45.85M | -45.43M | -41.44M | -38.70M | -28.29M |
| Net Income | -40.05M | -45.85M | -45.43M | -41.44M | -38.70M | -28.29M |
| Preferred Dividends & Other Adjustments | 25.00K | 25.00K | 24.00K | 24.00K | 24.00K | 24.00K |
| Net Income to Common | -40.08M | -45.88M | -45.45M | -41.47M | -38.73M | -28.32M |
| Shares Outstanding (Basic) | 67.77M | 66.84M | 47.65M | 44.68M | 43.60M | 39.03M |
| Shares Outstanding (Diluted) | 67.77M | 66.84M | 47.65M | 44.68M | 43.60M | 39.03M |
| EPS (Basic) | -0.59 | -0.69 | -0.95 | -0.93 | -0.89 | -0.73 |
| EPS (Diluted) | -0.59 | -0.69 | -0.95 | -0.93 | -0.89 | -0.73 |
| Free Cash Flow | -40.92M | -37.97M | -37.77M | -31.47M | -34.83M | -23.25M |
| Free Cash Flow Per Share | -0.60 | -0.57 | -0.79 | -0.70 | -0.80 | -0.60 |
| Operating Margin | -8,320.08% | -8,256.32% | -7,123.13% | -9,305.74% | -10,337.31% | -8,037.60% |
| Profit Margin | -7,888.98% | -7,736.26% | -6,655.20% | -8,496.93% | -10,033.16% | -7,887.19% |
| Free Cash Flow Margin | -8,054.33% | -6,402.53% | -5,530.45% | -6,448.57% | -9,022.28% | -6,474.93% |
| EBITDA | -41.91M | -48.60M | -48.25M | -45.01M | -39.67M | -28.40M |
| D&A For EBITDA | 351.00K | 364.00K | 404.00K | 398.00K | 236.00K | 451.00K |
| EBIT | -42.27M | -48.96M | -48.65M | -45.41M | -39.90M | -28.86M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.20M | 17.47M | 51.47M | 21.66M | 16.35M | 11.94M |
| Short-Term Investments | 25.32M | 40.83M | 40.28M | 53.17M | 88.92M | 128.88M |
| Cash & Short-Term Investments | 34.52M | 58.30M | 91.75M | 74.82M | 105.27M | 140.82M |
| Accounts Receivable | 189.00K | 182.00K | 773.00K | 288.00K | 771.00K | 535.00K |
| Other Receivables | 300.00K | 400.00K | 600.00K | |||
| Receivables | 189.00K | 482.00K | 1.17M | 888.00K | 771.00K | 535.00K |
| Prepaid Expenses | 883.00K | 1.34M | 2.13M | 1.70M | 5.25M | 4.77M |
| Total Current Assets | 35.59M | 60.13M | 95.05M | 77.41M | 111.28M | 146.13M |
| Property, Plant & Equipment | 810.00K | 1.21M | 2.07M | 2.95M | 3.52M | 3.18M |
| Other Long-Term Assets | 927.00K | 549.00K | 69.00K | 1.28M | 1.39M | 239.00K |
| Total Assets | 37.33M | 61.88M | 97.19M | 81.64M | 116.19M | 149.54M |
| Accounts Payable | 3.99M | 8.09M | 4.82M | 1.97M | 1.96M | 1.44M |
| Accrued Expenses | 6.35M | 6.83M | 7.90M | 7.78M | 5.18M | 4.11M |
| Current Portion of Leases | 457.00K | 730.00K | 710.00K | 691.00K | 675.00K | 551.00K |
| Other Current Liabilities | 744.00K | 456.00K | ||||
| Total Current Liabilities | 10.80M | 16.39M | 13.43M | 10.44M | 7.81M | 6.56M |
| Long-Term Leases | 102.00K | 813.00K | 1.46M | 2.04M | 2.57M | |
| Total Liabilities | 10.80M | 16.50M | 14.24M | 11.90M | 9.85M | 9.13M |
| Common Stock | 7.00K | 7.00K | 7.00K | 4.00K | 4.00K | 4.00K |
| Additional Paid-In Capital | 478.19M | 475.36M | 467.09M | 409.34M | 404.83M | 400.50M |
| Retained Earnings | -451.61M | -430.03M | -384.18M | -339.54M | -298.10M | -259.81M |
| Comprehensive Income & Other | -62.00K | 50.00K | 34.00K | -67.00K | -395.00K | -281.00K |
| Total Common Equity | 26.53M | 45.39M | 82.95M | 69.74M | 106.34M | 140.42M |
| Shareholders' Equity | 26.53M | 45.39M | 82.95M | 69.74M | 106.34M | 140.42M |
| Total Liabilities & Equity | 37.33M | 61.88M | 97.19M | 81.64M | 116.19M | 149.54M |
| Total Debt | 457.00K | 832.00K | 1.52M | 2.15M | 2.71M | 3.12M |
| Net Cash (Debt) | 34.06M | 57.47M | 90.22M | 72.67M | 102.55M | 137.70M |
| Net Cash Per Share | 0.50 | 0.86 | 1.89 | 1.63 | 2.35 | 3.53 |
| Filing Date Shares Outstanding | 77.80M | 68.36M | 66.52M | 44.68M | 44.68M | 43.31M |
| Total Common Shares Outstanding | 68.50M | 68.31M | 66.52M | 44.68M | 44.68M | 41.96M |
| Working Capital | 24.80M | 43.73M | 81.63M | 66.97M | 103.48M | 139.57M |
| Book Value Per Share | 0.39 | 0.66 | 1.25 | 1.56 | 2.38 | 3.35 |
| Tangible Book Value | 26.53M | 45.39M | 82.95M | 69.74M | 106.34M | 140.42M |
| Tangible Book Value Per Share | 0.39 | 0.66 | 1.25 | 1.56 | 2.38 | 3.35 |
| Machinery | 2.18M | 2.48M | 2.47M | 2.42M | 2.12M | 1.86M |
| Leasehold Improvements | 2.57M | 2.57M | 2.57M | 2.57M | 2.56M | 1.96M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -40.05M | -45.85M | -45.43M | -41.44M | -38.70M | -28.29M |
| Depreciation & Amortization | 890.00K | 904.00K | 943.00K | 398.00K | 236.00K | 451.00K |
| Loss (Gain) From Sale of Assets | 1.00K | 1.00K | ||||
| Loss (Gain) From Sale of Investments | -567.00K | -848.00K | -598.00K | -921.00K | 632.00K | 1.61M |
| Stock-Based Compensation | 5.22M | 5.69M | 4.76M | 4.51M | 4.26M | 3.23M |
| Other Operating Activities | 139.00K | 1.75M | ||||
| Change in Accounts Receivable | 337.00K | 591.00K | -484.00K | 483.00K | -236.00K | -215.00K |
| Change in Accounts Payable | -6.34M | 2.20M | 2.98M | 2.83M | 1.35M | 719.00K |
| Change in Other Net Operating Assets | -343.00K | -614.00K | 132.00K | 3.25M | -1.49M | -2.29M |
| Operating Cash Flow | -40.85M | -37.92M | -37.69M | -30.89M | -33.82M | -23.04M |
| Capital Expenditures | -62.00K | -44.00K | -80.00K | -582.00K | -1.01M | -205.00K |
| Investment in Securities | 36.50M | 1.39M | 13.81M | 36.78M | 39.04M | -131.24M |
| Other Investing Activities | 114.00K | |||||
| Investing Cash Flow | 36.44M | 1.34M | 13.73M | 36.20M | 38.15M | -131.45M |
| Issuance of Common Stock | 2.90M | 2.58M | 53.78M | 75.00K | 36.26M | |
| Other Financing Activities | -64.00K | -813.00K | ||||
| Financing Cash Flow | 2.83M | 2.58M | 53.78M | 75.00K | 35.45M | |
| Net Cash Flow | -1.59M | -34.00M | 29.82M | 5.31M | 4.40M | -119.04M |
| Free Cash Flow | -40.92M | -37.97M | -37.77M | -31.47M | -34.83M | -23.25M |
| Free Cash Flow Margin | -8,054.33% | -6,402.53% | -5,530.45% | -6,448.57% | -9,022.28% | -6,474.93% |
| Free Cash Flow Per Share | -0.60 | -0.57 | -0.79 | -0.70 | -0.80 | -0.60 |
| Levered Free Cash Flow | -24.30M | -19.62M | -22.53M | -18.01M | -21.04M | -16.74M |
| Unlevered Free Cash Flow | -24.30M | -19.62M | -22.53M | -18.01M | -21.04M | -16.74M |
| Cash Income Tax Paid | 1.00K | 1.00K | 1.00K | 2.00K | 1.00K | |
| Change in Working Capital | -6.35M | 2.18M | 2.63M | 6.57M | -380.00K | -1.79M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 65.68M | 189.28M | 288.71M | 66.12M | 62.55M | 252.20M |
| Enterprise Value | 31.62M | 129.70M | 232.73M | -12.95M | -48.91M | 121.44M |
| Last Close Price | 0.89 | 2.81 | 4.34 | 1.48 | 1.40 | 6.01 |
| PS Ratio | 128.64 | 319.20 | 422.72 | 135.50 | 162.04 | 702.51 |
| PB Ratio | 2.30 | 4.17 | 3.48 | 0.95 | 0.59 | 1.80 |
| P/TBV Ratio | 2.46 | 4.17 | 3.48 | 0.95 | 0.59 | 1.80 |
| EV/Sales Ratio | 61.58 | 218.72 | 340.75 | 338.27 | ||
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Net Debt / Equity Ratio | -1.28 | -1.27 | -1.09 | -1.04 | -0.96 | -0.98 |
| Net Debt / EBITDA Ratio | 0.81 | 1.18 | 1.87 | 1.61 | 2.58 | 4.85 |
| Net Debt / FCF Ratio | 0.83 | 1.51 | 2.39 | 2.31 | 2.94 | 5.92 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Quick Ratio | 3.21 | 3.59 | 6.92 | 7.25 | 13.58 | 21.55 |
| Current Ratio | 3.30 | 3.67 | 7.08 | 7.42 | 14.25 | 22.28 |
| Return on Equity (ROE) | -94.08% | -71.45% | -59.51% | -47.07% | -31.37% | -21.07% |
| Return on Assets (ROA) | -46.73% | -38.47% | -34.01% | -28.69% | -18.77% | -12.69% |
| Return on Capital Employed (ROCE) | -159.30% | -107.60% | -58.10% | -63.80% | -36.80% | -20.20% |
| Earnings Yield | -70.05% | -24.22% | -15.74% | -62.67% | -61.88% | -11.22% |
| FCF Yield | -62.61% | -20.06% | -13.08% | -47.59% | -55.68% | -9.22% |
| Buyback Yield / Dilution | -15.77% | -40.27% | -6.65% | -2.47% | -11.71% | -86.97% |